N910Remark Code (RARC)Active
Effective 03/01/2025

N910 Remark Code - No Refund Available for Claim

The N910 remark code indicates that a refund cannot be provided for the claim at this time. It instructs the biller to contact the manufacturer directly to discuss eligibility for a refund related to the Medicare Drug Price Negotiation Program.

How It Relates to the Denial

N910 typically accompanies a Claim Adjustment Reason Code that indicates a denial or adjustment related to drug pricing under the Medicare program. The combination of these codes signals that while there may be an adjustment noted, further action must be taken with the manufacturer regarding the refund eligibility.

Common Scenarios

1A pharmacy submitted a claim for a medication covered under the Medicare Drug Price Negotiation Program, expecting a refund due to a pricing dispute.
→ The N910 remark suggests that the pharmacy cannot receive a refund for this claim right now and must reach out to the manufacturer to determine if they qualify for a refund.
2A healthcare provider billed for a drug that was negotiated under Medicare, but the claim was adjusted with a reason code indicating no refund is available.
→ In this case, the N910 remark clarifies that the provider should not expect a refund and must contact the drug manufacturer for eligibility details.
3A claim for a prescribed medication was denied due to pricing issues linked to the Medicare Drug Price Negotiation Program, resulting in an adjustment on the remittance advice.
→ The presence of N910 indicates that while the claim has been adjusted, the provider should engage with the manufacturer to explore any potential refund eligibility.

What to Do

  1. Contact the manufacturer directly to inquire about refund eligibility for the claim.
  2. Do not attempt to resubmit the claim for a refund without first consulting with the manufacturer.

What to Check

  • Review the claim adjustment reason code that accompanies N910 to understand the specifics of the adjustment.
  • Check any correspondence or documentation from the manufacturer regarding refund policies.
  • Verify that the claim falls under the Medicare Drug Price Negotiation Program as indicated in the official notes.